PAWR, implicated in various cancers, and S100A8, a regulator of inflammatory responses, further expanded the repertoire of potential therapeutic targets (Rah et al., 2015; Pruenster et al., 2016; Tan et al., 2020; He et al., 2021). This evidence concerns the gene PAWR and cancer.